Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease

JAMA Author Interviews
22/09/2015 3 min
Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease

Listen "Dextromethorphan-Quinidine for Agitation in Patients With Alzheimer Disease"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Jeffrey L. Cummings, MD, ScD, author of Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial

More episodes of the podcast JAMA Author Interviews

The Sequential Organ Failure Assessment (SOFA)-2 Score 29/10/2025
From the JAMA Network: Acetaminophen Use in Pregnancy and Risk of Autism 30/09/2025
From the JAMA Network: AI-Based Analysis for Parkinsonism 30/08/2025
Treatment of Complicated Staphylococcus aureus Bacteremia 13/08/2025
From the JAMA Network: Incidence and Nature of Antidepressant Discontinuation Symptoms 05/08/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 28/07/2025
Life Support and Outcomes in Patients Admitted to Intensive Care Units 14/04/2025
Increases in Invasive Group A Streptococcal Infections 07/04/2025
Preventive Health Care Among Adults Eligible for Lung Cancer Screening 02/04/2025
Cardiac Arrests During Long-Distance Running: What's Changed? 30/03/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA